BIOMAT Database Logo BIOMAT Database Logo

Phase II trial of diaziquone in advanced renal adenocarcinoma. 1984

M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001388 Aziridines Saturated azacyclopropane compounds. They include compounds with substitutions on CARBON or NITROGEN atoms. Ethyleneimines,Azacyclopropanes, Saturated,Dimethyleneimines,Saturated Azacyclopropanes
D001389 Azirines Unsaturated azacyclopropane compounds that are three-membered heterocycles of a nitrogen and two carbon atoms. Azacyclopropanes, Unsaturated,Unsaturated Azacyclopropanes
D016227 Benzoquinones Benzene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. 1,2-Benzoquinones,1,4-Benzoquinones,Benzodiones,2,5-Cyclohexadiene-1,4-Diones,o-Benzoquinones,p-Benzoquinones

Related Publications

M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II trial of diaziquone in advanced upper aerodigestive cancer.
January 1985, Cancer treatment reports,
M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
February 1983, European journal of cancer & clinical oncology,
M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II trial of diaziquone in malignant mesothelioma.
March 1986, Cancer treatment reports,
M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II clinical trial of diaziquone in bronchogenic carcinoma.
January 1985, Cancer treatment reports,
M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II trial of esorubicin in advanced pancreatic adenocarcinoma.
May 1986, Cancer treatment reports,
M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II trial of diaziquone in patients with colon cancer.
February 1985, Cancer treatment reports,
M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II trial of fenretinide in advanced renal carcinoma.
March 2005, Investigational new drugs,
M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
March 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
November 1992, Investigational new drugs,
M Hansen, and W M Gallmeier, and J Vermorken, and E Holdener, and H H Hansen, and J Renard, and M Rozencweig
Phase II study of diaziquone in patients with advanced carcinoma of the lung.
September 1984, Cancer treatment reports,
Copied contents to your clipboard!